Don’t miss the opportunity to join your colleagues at the 2014 ACCP Annual Meeting, October 12–15, in Austin, Texas. Register now for early-bird registration rates and begin building your Annual Meeting itinerary around these curricular tracks, each designed to stimulate in-depth learning:
Curricular Track I—Medication Safety will focus on advancing medication safety using technology such as a closed-loop system to optimize medication error prevention and a real-time active medication monitoring system to prevent medication errors and ADEs. Speakers will discuss the evolution of Risk Evaluation and Mitigation Strategies (REMS) and provide updates, compare and contrast medication error reporting programs for the U.S. Food and Drug Administration (FDA) and the Institute for Safe Medication Practices (ISMP), and provide methods for applying recent FDA safety communications to your everyday practice. This curricular track will also focus on integrating safety and quality data to support clinical pharmacy services, improving the safety of off-label uses of medications, and integrating patient safety organizations (PSOs) into clinical pharmacy practice.
Curricular Track II—Emerging Issues, Challenges, Concepts in Infectious Diseases will include updates and challenges in managing drug-resistant gram-negative pathogens, an update on new clinical guidelines in infectious diseases, and discussions of the clinical utility of active surveillance in the hospital setting. Speakers will focus on the rapid identification of fungal infections, antifungal resistance, and preemptive antifungal therapy in special populations. This curricular track will also discuss the resurgence of communicable infectious diseases, new indications for old antimicrobials, and multidrug-resistant tuberculosis.
Curricular Track III—Clinical Controversies will discuss a series of clinical controversies, including the effect of colchicine in acute coronary syndromes, the use of statins in patients with sepsis, and the use of combination tPA and dornase alfa therapy for pleural infection. Speakers will also discuss conundrums in published clinical guidelines, including a brief review of the current blood cholesterol guideline recommendation for CV risk reduction, a review of the supporting evidence regarding the use of goal-oriented strategy, and a response to conflicting stances focusing on the use of evidence-based strategies. Concluding presentations will be centered on clinical controversies in analgesia/anesthesia, with a focus on specific cases.
The 2014 ACCP Annual Meeting programming will also include 21 highly specialized Practice and Research Network (PRN) focus sessions, ACCP Academy core programming focusing on key professional development issues, the Residency and Fellowship Forum for the recruitment of 2015–2016 residents and fellows, ACCP’s Clinical Pharmacy Challenge, and much more!
Early registration for the 2014 Annual Meeting ends September 5. Don’t miss out on early-bird savings—register online today!